openPR Logo
Press release

Neisseriaceae Infections Market Progresses for Huge Profits During 2020

01-02-2018 12:55 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Neisseriaceae Infections Market Progresses for Huge Profits

Bacteria represent the essential class of micro-organisms that play a crucial role in the development of infection of any disease to human being and animal. Bacteria are divided into two types on the basis of gram staining test, namely; gram-positive bacteria and gram-negative bacteria. Neisseria is one of the most important genera of bacteria which form colonies on mucosal surfaces of various animals. Neisseria consists of 11 species, out of which, two are pathogenic and others are harmless. These belong to gram negative class of bacteria, since these species show negative response to gram test.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/neisseriaceae-infections-market.html

The market of Neisseriaceae infections is segmented on the basis of various bacteria that belongs to the class and diseases associated with them, such as, Acinetobacter, Kingella, Neisseria, Moraxella and Oligella. Neisseria contains bacteria such as N. meningitidis, N. gonorrhoeae, N. sicca, N. flava, N. elongata, N. cinerea and others. Out of which, N. gonorrhoeae causes gonorrhea and N. meningitidis causes septicemia and meningitis. Moraxella catarrhalis causes sinusitis, otitis, and pneumonia in adults. Kingella kingae causes CNS, urinary and respiratory infections. Moreover, it is segmented on the basis of antibacterial drugs, such as, B-lactum antibiotics (Penicillin), clavulanic acid (Augmentin), aminoglycosides (Streptomycin), glycopeptides (Vancomycin), polypeptides (Bacitracin), rifamycins (Rifampicin), chloramphenicol, tetracycline and many others. In addition, the market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). At present, North America and Europe are the most prominent markets, owing to growing prevalence of various Neisseriaceae infections and associated disease. However, Asia-Pacific and some countries in RoW region are expected to show lucrative growth in the upcoming period, owing to rapidly growing prevalence and awareness about the diseases caused due to Neisseriaceae and their chronic effects.

The market is expected to show a steady growth during the forecast period from 2014 – 2020. This growth is expected to be driven by many factors, such as, increasing prevalence of Neisseriaceae infections and extensive R&D practices ongoing globally. In addition, rising prevalence of infection diseases is the most important factor that drives the growth of the market to a higher end.

Request for Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3572

According to the U.S. Centers for Disease Control and Prevention (CDC), more than 300,000 new cases of gonorrhea were reported in the U.S. in 2012, an increase of around 4% compared to 2011. Thus, such rising prevalence of infections is an important growth driver of the market. Further, due to extensive R&D practices, number of drugs and formulations are on the way to enter in the market during the forecast period 2014 – 2020. Some of the important pipeline products include AXD0914, Cribrostatin-6, SM-295291 and SM-369926 amongst numerous others. Additionally, due to increased incidences of homosexuality and bisexuality, the threat of gonorrhea has also increased. These factors are supported by rising awareness about the infections and diseases and increasing medical expenditure. Owing to these, the market is expected to grow at steady rate. On the other hand, factors such as government austerity, high cost of treatment and R&D, and ignorance towards the symptoms may hamper the growth of the market to certain extent. Some of the major players engaged in R&D and commercialization of the products in the market include Basilea Pharmaceuticals Ltd., AstraZeneca plc, Adenium Biotech ApS, Dainippon Sumitomo Pharma Co., Ltd., Aphios Corporation, Pfizer, Inc., GSK plc, Theravance, Inc., and Pfizer, Inc. amongst many others.

Pre Book this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=3572<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neisseriaceae Infections Market Progresses for Huge Profits During 2020 here

News-ID: 881775 • Views: 103

More Releases from Transparency Market Research

Latest TMR Report Explores Impact of COVID-19 Outbreak on Industrial Air Compres …
Industrial Air Compressor Market: Introduction The global industrial air compressor market is anticipated to reach US$ 26.6 Bn by 2030. The industrial air compressor market is projected to expand at a CAGR of ~4% from 2020 to 2030 based on revenue. According to the report, Asia Pacific was a significant contributor to the industrial air compressor market in terms of revenue in 2019. The prominent market share of the region is
Automotive Head-up Display (HUD) Market is projected to surpass US$ 4.7 Bn by 20 …
Automotive Head-up Display (HUD) Market: Introduction According to the report, the global automotive head-up display (HUD) market is projected to surpass US$ 4.7 Bn by 2030, expanding at a CAGR of ~22% during the forecast period. Rise in demand for comfort and safety features in vehicles is likely to boost the automotive head-up display (HUD) market across the globe. Increase in preference for utility vehicles and luxury vehicles, in conjunction with
Understanding Impact of COVID-19 on Retail Clinics Market
Global Retail Clinics Market – Overview Retail clinics are the ones that provide primary healthcare services across departmental stores, supermarkets, and retail stores. These clinics have a registration desk, a waiting area, washroom, a couple of examination rooms, and a small desk for reception. These retail clinics are gaining immense popularity as they are highly beneficial for public health, easily accessible, and also help in reducing the pressure on public healthcare
Potential Impact of COVID-19 on Self-tanning Products Market
Self-tanning Products Market: Introduction Transparency Market Research delivers key insights on the global self-tanning products market. In terms of revenue, the global self-tanning products market is estimated to expand at a CAGR of ~6% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in the global self-tanning products market report. Obtain Report Details @ https://www.transparencymarketresearch.com/self-tanning-products-market.html In terms of type, the self-tanning products market has been segmented

All 5 Releases


More Releases for Neisseria

Chlamydia Trachomatis And Neisseria Gonorrhoeae (CT/NG) Molecular Diagnostics Ma …
The global Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) molecular diagnostics market was valued at $ 118.7 Million in 2017 and is forecast to grow at a modest 19.05 % CAGR between 2018 and 2025, culminating in 2025 global sales of $ 402.2 Million. Causal organism for infectious diseases could be bacteria, viruses, parasites or fungi and can be spread, directly or indirectly, from one person to another. Molecular diagnostic is
Neisseria meningitidis Infections Drug Market Will Hit Big Revenues In Future Wi …
Up Market Research added a new Neisseria meningitidis Infections Drug Market research report for the period of 2019 –2026. Report focuses on the major drivers and restraints providing analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. Get Sample Copy Of This Report @ https://www.upmarketresearch.com/home/requested_sample/95906 The report contains 101 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing
Meningococcal Conjugate Vaccine Market Value set to reach industry expectations …
Meningococcal vaccine is used to prevent contagious infection of the membranes that surround the brain and spinal cord caused by Neisseria meningitides. Three types of vaccines are present to act against meningococcal disease which target serogroups A, C, W-135, and Y of meningococcus. These vaccines are mainly used to immunize infants and children against invasive diseases caused by Neisseria meningitides. The major factors that contribute to the growth of the meningococcal
Neisseria Meningitidis Infections Antibiotics Market: Increasing Number of Geria …
Neisseria Meningitidis is a severe bacterial infection of the bloodstream and meninges (a thin lining covering the brain and spinal cord). Symptoms include fever, neck stiffness, joint pain, nausea, confusion and drowsiness. Risk factors include age, smoking, mucosal lesions, overcrowding, climatic conditions such as dry seasons or prolonged drought and dust storms and concomitant respiratory infections. To evaluate various factors influencing growth of Neisseria meningitidis infections antibiotics market, Market Research Hub
Neisseria meningitidis Infections Drug Market Enhancement in Medical Sector 2017 …
Worldwide Market Reports added Latest Research Report titled “Neisseria meningitidis Infections Drug Market Enhancement in Medical Sector 2017 to 2022”. The global Neisseria meningitidis Infections Drug market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. To know more about CAGR figures fill in your information so that our business
Neisseria meningitidis Infections (Infectious Disease) Pipeline Forecast Report, …
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Neisseria meningitidis Infections - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Neisseria meningitidis Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news